0001019687-15-004483.txt : 20151211
0001019687-15-004483.hdr.sgml : 20151211
20151211160553
ACCESSION NUMBER: 0001019687-15-004483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151027
FILED AS OF DATE: 20151211
DATE AS OF CHANGE: 20151211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medytox Solutions, Inc.
CENTRAL INDEX KEY: 0001374536
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 900902741
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
BUSINESS PHONE: 561-855-1626
MAIL ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
FORMER COMPANY:
FORMER CONFORMED NAME: CASINO PLAYERS, INC.
DATE OF NAME CHANGE: 20060905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diamantis Christopher Eric
CENTRAL INDEX KEY: 0001578723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54346
FILM NUMBER: 151283329
MAIL ADDRESS:
STREET 1: 400 SOUTH AUSTRALIAN AVENUE
STREET 2: 8TH FLOOR
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
4
1
dimantis_frm4.xml
FORM 4
X0306
4
2015-10-27
1
0001374536
Medytox Solutions, Inc.
MMMS
0001578723
Diamantis Christopher Eric
400 S. AUSTRALIAN AVENUE, 8TH FLOOR
WEST PALM BEACH
FL
33401
1
0
0
0
Common Stock
2015-10-27
4
P
0
100000
1.00
A
850000
D
Common Stock
2015-11-02
4
D
0
850000
D
0
D
Options to Purchase Common Stock
5.00
2015-11-02
4
D
0
100000
A
2013-04-19
2017-04-19
Common Stock
100000
0
D
Options to Purchase Common Stock
5.00
2015-11-02
4
D
0
50000
A
2014-04-19
2017-04-19
Common Stock
50000
0
D
Options to Purchase Common Stock
2.50
2015-11-02
4
D
0
100000
A
2013-04-19
2017-04-19
Common Stock
100000
0
D
Options to Purchase Common Stock
2.50
2015-11-02
4
D
0
50000
A
2014-04-19
2017-04-19
Common Stock
50000
0
D
Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub"), and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 348,193 shares of Rennova common stock.
Cancelled pursuant to merger agreement and related transactions between Medytox and Rennova.
Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 40,963 shares of Rennova common stock at an exercise price of $6.11 per share.
Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 20,481 shares of Rennova common stock at an exercise price of $6.11 per share.
/s/ Christopher Eric Diamantis
2015-12-11